This inventor holds 6 USPTO granted patents and 2 EPO patents. Top assignees: Dainippon Sumitomo Pharma Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Sumitomo Pharmaceuticals Company Limited. Active years: 2006-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ibaraki, JP (2006 - 2010)
- Oklahoma City, OK (US) (2011)
- Osaka, JP (2012 - 2015)
Company Filing History:
4 out of 140 
1 out of 110 
1 out of 174 Years Active: 2006-2015
Title: The Innovative Contributions of Toshihiro Noguchi
Introduction
Toshihiro Noguchi is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 6 patents to his name, Noguchi's work has the potential to impact the lives of many patients.
Latest Patents
Among his latest patents, one notable invention is a medicament for the treatment of cancer. This medicament is designed for use in combination therapy with an anti-HER2 antibody and comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient. Another significant patent focuses on treating lung cancer effectively by combining amrubicin or a pharmaceutically acceptable salt thereof with cisplatin. These innovations highlight Noguchi's commitment to advancing cancer therapies.
Career Highlights
Throughout his career, Toshihiro Noguchi has worked with reputable companies such as Dainippon Sumitomo Pharma Co., Ltd. and Sumitomo Pharmaceuticals Company Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.
Collaborations
Noguchi has collaborated with several talented individuals in his field, including Akemi Baba and Mitsuharu Hanada. These partnerships have contributed to the success of his projects and the advancement of cancer treatment options.
Conclusion
Toshihiro Noguchi's contributions to cancer treatment through his innovative patents demonstrate his dedication to improving healthcare. His work continues to inspire future advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile